SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Histogenics Corporation (HSGX)

Add HSGX Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 1/26/2016 8:11:57 PM - Followers: 3 - Board type: Free - Posts Today: 0
Histogenics Corporation
830 Winter Street
3rd Floor
Waltham, MA 02451
United States
Phone: 781-547-7900
Fax: 781-547-4452

Histogenics Corporation develops and commercializes regenerative medicine products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, a first-line therapy for full thickness knee chondral lesions in skeletally mature adults age 18 to 55. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
HSGX News: Histogenics Corporation to Ring the Nasdaq Stock Market Closing Bell 10/13/2016 08:30:00 AM
HSGX News: Small Company Offering and Sale of Securities Without Registration (d) 10/12/2016 05:26:34 PM
HSGX News: Histogenics Corporation (Nasdaq: HSGX), to Ring The Nasdaq Stock Market Closing Bell 10/12/2016 10:00:00 AM
HSGX News: Histogenics Corporation Announces Addition of Dr. Lawrence Bonassar of Cornell University to Its Scientific Advisory Board 10/06/2016 04:05:00 PM
HSGX News: Amended Statement of Beneficial Ownership (sc 13d/a) 10/06/2016 11:43:33 AM
#4   Short squeeze happening !! Hey Ray 01/26/16 08:11:57 PM
#3   Liking HSGX Hey Ray 01/26/16 05:09:24 PM
#2   Panda (ll) etcetera 12/31/15 10:25:19 AM
#1   $HSGX recent news/filings stocktrademan 11/13/15 04:20:27 PM